片野いくみ

Ikumi Katano

競争的資金等の研究課題 (4件)：

論文 (42件)：

Ryo Akazawa, Takashi Mikami, Masaki Yamada, Itaru Kato, Hirohito Kubota, Satoshi Saida, Yoshinori Uchihara, Yuriko Ishikawa, Tatsuya Kamitori, Keiji Tasaka, et al. Multiomics analysis reveals the genetic and epigenetic features of high-risk NK cell-type chronic active EBV infection. Blood Journal. 2025
Ito R, Katano I, Kwok IWH, Ng LG, Ida-Tanaka M, Ohno Y, Mu Y, Morita H, Nishinaka E, Nishime C, et al. Efficient differentiation of human neutrophils with recapitulation of emergency granulopoiesis in human G-CSF knockin humanized mice. Cell reports. 2022
Ikumi Katano, Asami Hanazawa, Iyo Otsuka, Takuya Yamaguchi, Misa Mochizuki, Kenji Kawai, Ryoji Ito, Motohito Goto, Takahiro Kagawa, Takeshi Takahashi. Development of a novel humanized mouse model for improved evaluation of in vivo anti-cancer effects of anti-PD-1 antibody. Scientific reports. 2021. 11. 1. 21087-21087
Ryoji Ito, Ikumi Katano, Iyo Otsuka, Takeshi Takahashi, Hiroshi Suemizu, Mamoru Ito, Peter J Simons. Bovine β-lactoglobulin-induced passive systemic anaphylaxis model using humanized NOG hIL-3/hGM-CSF transgenic mice. International immunology. 2021. 33. 3. 183-189
Takuya Yamaguchi, Ikumi Katano, Iyo Otsuka, Ryoji Ito, Misa Mochizuki, Motohito Goto, Takeshi Takahashi. Generation of Novel Human Red Blood Cell-Bearing Humanized Mouse Models Based on C3-Deficient NOG Mice. Frontiers in immunology. 2021. 12. 671648-671648

MISC (3件)：

A. Miyamoto, Katano, I, Y. Kikuchi, B. Tsuda, Y. Tokuda, M. Ito, S. Habu, Y. Kametani. The specific antibody production against HER2 peptide CH401MAP in NOG-IL4-Tg mice. EUROPEAN JOURNAL OF IMMUNOLOGY. 2016. 46. 1218-1218
Caroline Mignard, Jean-Francois Mirjolet, Olivier Duchamp, Yasuyuki Ohnishi, Ikumi Katano, Mamoru Ito. Pharmacodynamic evaluation of ADCC mediated effects in humanized IL2 or IL15 NOG mice models. CANCER RESEARCH. 2014. 74. 19
Caroline Mignard, Olivier Duchamp, Jean-Francois Mirjolet, Yasuyuki Ohnishi, Ikumi Katano, Mamoru Ito. In vivo ADCC-mediated antitumor activity study with new preclinical humanized models. MOLECULAR CANCER THERAPEUTICS. 2013. 12. 11

学位 (1件)：

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

片野 いくみ